An underground market for unlicensed weight-loss medications is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.
Experimental Drug Gaining Traction Via Social Media
The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its alleged fat-burning effects. Viewers are encouraged to contact these accounts directly for supplier links, while also receiving promotional offers.
Thriving Commerce on Messaging Platforms
Additionally, a robust trade exists on messaging services, where groups with thousands of participants share “before and after” images, administration instructions and claims of rapid UK delivery. Vendors promote the drug there before redirecting buyers to WhatsApp for transactions.
Understanding The Experimental Drug
This medication is an experimental injection developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.
Healthcare Professionals Voice Worries
Nevertheless, physicians and pharmacists have cautions that the distribution of what remains an unlicensed medication in the United Kingdom is a cause for concern and could lead to individuals injecting products of unknown origin.
Some experts said the demand for retatrutide could be linked to the increasing cost of licensed slimming products such as Mounjaro.
Regulatory Position and Implementation
Selling retatrutide on social media or Telegram is illegal in the UK, as it is an unlicensed drug that must not be promoted or distributed for personal consumption under the British medical regulations.
Some content creators attempt to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and distribution can still violate pharmaceutical, advertising, and customer laws, risking penalties, prosecution or imprisonment.
Service Response and Content Removal
Based on TikTok, the platform has removed problematic content and banned related keywords and query recommendations. The company stated it was dedicated to keeping the service secure and allocating resources in strengthening enforcement strategies.
Digital Marketplace Activities
Research also discovered groups with up to 9,000 members marketing retatrutide using the platform's built-in discovery tool, which operates like a public directory. Typing “retatrutide” instantly brings up channels with numerous of members, filled with images of weight loss, positive reviews and detailed guides for preparing or injecting at residence.
Within minutes of entering one group, a vendor posted contact information, where the majority of transactions occur. The seller sent an guidebook and guaranteed shipping within 48 hours. When questioned whether the substance was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one inquired about body mass, medical conditions or previous experience.
Item Details and Pricing
Inside these communities, messages display dark colored parcels with postal service stickers, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, mixed at home with purified liquid, or ready-to-use pens usually sold at £160 for 20mg. When questioned how long a pen should last, vendors give contradictory answers ranging from a several days to “depends on your body”.
Platform Oversight and Security Actions
A spokesperson for the messaging service said it actively moderated dangerous content on its service including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Cautions
“People are administering substances they can’t verify. Although the research behind this drug is sound, these online versions may not include what they claim,” stated Jason Murphy, the director of pharmacy at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor connected the increase in interest to recent price rises for authorized slimming medications such as Mounjaro. “With prices increasing, patients are using online platforms. But fake treatments are highly risky. You cannot know what’s inside or whether the conditions they were made in was clean,” she explained.
Her staff has already encountered individuals injured by self-injection from unconfirmed suppliers. “We recognize the frustration, but buying from messaging apps or communication platforms is gambling with your well-being,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Position
A representative from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they explained, adding that any product “misleadingly claiming itself as a company investigational product not yet approved … may subject users to possibly serious medical dangers”.
